Psychiatric medicines in India: why public healthcare facilities and a thriving generics industry cannot assure access and affordability

Abstract

This commentary highlights the poor availability of essential psychiatric medicines at public sector facilities in India and illustrates why even a flourishing generics industry does not assure access to affordable psychiatric medicines for most Indian patients. The paper outlines the Indian government's pricing regulations and then enumerates recommendations for reform.